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Objective. To analyze the impact of decannulation before intensive care unit discharge 
on ward survival in nonexperimental conditions. 
Design. Prospective, observational survey. 
Setting. Thirty-one intensive care units throughout Spain.  
Patients. All patients admitted from March 1, 2008 to May 31, 2008. 
Interventions. None. 
Measurements and Main Results. At intensive care unit discharge, we recorded 
demographic variables, severity score, and intensive care unit treatments, with special 
attention to tracheostomy. After intensive care unit discharge, we recorded intensive 
care unit readmission and hospital survival. Statistics: Multivariate analyses for ward 
mortality, with Cox proportional hazard ratio adjusted for propensity score for intensive 
care unit decannulation. We included 4,132 patients, 1,996 of whom needed mechanical 
ventilation. Of these, 260 (13%) were tracheostomized and 59 (23%) died in the 
intensive care unit. Of the 201 intensive care unit tracheostomized survivors, 60 were 
decannulated in the intensive care unit and 141 were discharged to the ward with 
cannulae in place. Variables associated with intensive care unit decannulation (non-
neurologic disease [85% vs. 64%], vasoactive drugs [90% vs. 76%], parenteral nutrition 
[55% vs. 33%], acute renal failure [37% vs. 23%], and good prognosis at intensive care 
unit discharge [40% vs. 18%]) were included in a propensity score model for 
decannulation. Crude ward mortality was similar in decannulated and nondecannulated 
patients (22% vs. 23%); however, after adjustment for the propensity score and Sabadell 
Score, the presence of a tracheostomy cannula was not associated with any survival 
disadvantage with an odds ratio of 0.6 [0.3–1.2] (p = .1). 
Conclusion. In our multicenter setting, intensive care unit discharge before 
decannulation is not a risk factor. (Crit Care Med 2011; 39:2240–2245) 





Between 10% and 40% of patients with prolonged mechanical ventilation (MV) 
undergo tracheostomy either to improve comfort during prolonged MV or to shorten 
weaning (1–3). Whether tracheostomy improves the outcome of MV patients is 
controversial (4–6). Some studies report that tracheostomy expedites discharge to the 
ward, allowing better intensive care unit (ICU) resource allocation (7). However, some 
studies report higher ward mortality in cannulated patients (8, 9); thus, decannulation 
before ICU discharge is advocated. Nevertheless, extending the ICU stay to enable 
decannulation is expensive and occupies scarce ICU beds. A recent study reported that 
surveillance of tracheostomized patients in the ward by a dedicated team shortened the 
length of stay and increased survival (10). 
One observational study found that decannulation before ICU discharge decreased the 
risk of mortality in the ward in patients with poor short-term or long-term prognosis but 
had no effect on mortality in patients with good prognosis or in those expected to die in 
the hospital (11). 
A randomized clinical trial would be the best approach to definitively determine the 
possible clinical benefit of decannulation before ICU discharge, but the need to prolong 
ICU stays makes such trials unfeasible given the shortage of available ICU beds. In 
recent years, propensity scores have become common to adjust for confounding factors 
in observational studies (6). The propensity score is a predicted probability resulting 
from a model. Its main purpose is to control multiple confounders simultaneously and to 
account for treatment indication bias, and it is useful for maximizing the balance 
between the treatment groups. Clec’h et al (6) suggested that decannulation before ICU 
discharge is associated with better ward survival, but their propensity analysis was 
focused on the factors associated with tracheostomy, without a deep analysis of factors 
associated with decannulation. 
Therefore, we hypothesized that a sensitive observational analysis of the out-come of 
ICU tracheostomized patients may add important information about the possible 
benefits of decannulation before ICU discharge and that extracting the data from a wide 
variety of centers without intervening in standard medical practice would increase the 
strength of our conclusions. Therefore, we aimed to determine the impact of 
decannulation before ICU discharge on ward survival in nonexperimental conditions by 
using propensity analysis of the factors associated with decannulation before ICU 
discharge in data collected from a wide variety of sources for the validation of the 




MATERIALS AND METHODS 
 
We analyzed data from a prospective, multicenter cohort of 4,132 adult patients who 
were admitted to 31 ICUs in Spain during a 3-month period beginning March 1, 2008 
(the Appendix give a list of centers) (12). The local institutional review board at each 
participating center approved the study protocol and waived the need for consent. For 
the purpose of this predefined analysis, we selected only the patients who were 
tracheostomized during the ICU stay due to prolonged MV. 
In a specific Web-based database, we recorded the following variables for each patient 
admitted to the ICU: 1) on ICU admission, age, sex, diagnosis, predicted risk of death 
(Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology 
Score 2, or Simplified Acute Physiology Score 3, depending on each ICU’s clinical 
routine), source of admission, and do-not-resuscitate orders; 2) during the ICU stay, 
tracheal intubation, MV, noninvasive MV, vasoactive drugs, parenteral nutrition, blood 
transfusion, dialysis, tracheostomy, acute renal failure or infection acquired in the ICU, 
and prognosis assessed by the Sabadell Score (13); 3) after discharge from the ICU, 
ICU readmission and outcome. In patients readmitted to the ICU, only the first 
admission was included in the analysis. Briefly, the Sabadell Score classification system 
delineates four separate groups of patients: score 0, patients with good long-term 
prognosis; score 1, patients with poor long term prognosis (>6 months) and suitable for 
ICU readmission without restrictions; score 2, patients with poor prognosis in the short 
term (<6 months) and with debatable ICU readmission; score 3, patients not expected to 
survive the hospital stay. The score is fully subjective and integrates the physician’s 
knowledge about the patient’s conditions and functional derangement, as well as about 
the performance of the healthcare facility. The ward team was blind to the Sabadell 
Score; likewise, ICU physicians evaluating requests for ICU readmission were blind to 
the Sabadell Score. 
Decisions about whether and how to perform tracheostomy in the ICU, as well as 
whether and how to perform decannulation, remained at the discretion of the attending 
physicians, who were unaware of the study. 
The ward team was also unaware of the study; thus, the care of tracheostomized patients 
in the ward and decannulation, when feasible, should represent the standard treatment in 
most of our healthcare system. 
Follow-up variables were ICU readmission and 90-day ward outcome, even in patients 
who were transferred to another acute care hospital. 
 
Statistical Analysis. Categorical variables were expressed as percentages and compared 
using chi-square tests. Continuous variables were expressed as means and standard 
deviations and compared by one-way analysis of variance when normally distributed 
and were expressed as medians and 25% to 75% percentiles and compared by Kruskal-
Wallis analysis when non-normally distributed. Statistical significance was set at p < 
.05. 
The Cox regression estimate-of-survival curve was used for the univariate analysis of 
hospital mortality. The association of variables with ward mortality was assessed with 
backward multiple logistic regression. 
Since patients were not randomly assigned to decannulation and nondecannulation 
groups, we developed a propensity score using all the variables predictive of 
decannulation determined by logistic regression to account for treatment-indication bias 
and potentially confounding variables. Logistic regression identified the following 
variables as associated with decannulation: use of vasoactive drugs, ICU admission for 
non-neurologic disease, and absence of ICU-acquired infection. After testing the 
balanced distribution of variables across each quintile of the propensity scores, we 
elaborated a Cox regression estimate-of-survival curve for decannulated and 
nondecannulated patients, adjusting for quintiles and Sabadell Score as covariates. 
Analyses were performed with the Stata statistical program (version 10.0; StataCorp, 






We included 4,132 patients; 1,996 (48%) needed MV, and 260 (13%) of these were 
tracheostomized (Fig. 1). Table 1 shows the characteristics of mechanically ventilated 
patients grouped as tracheostomized and nontracheostomized patients. As has been 
commonly reported, tracheostomized patients were sicker and more commonly admitted 
from the ward and for respiratory and neurologic diseases. Tracheostomized patients 
required more ICU treatments (vasoactive drugs, transfusion, and parenteral nutrition) 
and had a higher frequency of acute renal failure and ICU-acquired infection as well as 
a longer stay in the ICU (median stay 28 vs. 5 days, p = .001). Furthermore, the 
subjective prognosis at ICU discharge by the Sabadell Score was also worse in 
survivors needing tracheostomy. Ward length of stay and hospital mortality were also 
higher in tracheostomized ICU patients than in nontracheostomized MV survivors. 
Finally, 59 (23%) tracheostomized patients died in the ICU, and 201 were discharged to 
the ward. Among the survivors, 60 (30%) were decannulated in the ICU and 141 (70%) 
were discharged to the ward with a cannula in place. 
Table 2 shows the characteristics of tracheostomized patients discharged to the ward 
according to their decannulation status. In the univariate analysis, the following factors 
were more common in patients decannulated before ICU discharge: non-neurologic 
disease (85% vs. 68%, p = .02), vasoactive drugs (90% vs. 76%, p = .01), parenteral 
nutrition (55% vs. 33%, p = .003), and acute renal failure (37% vs. 23%, p = .04). These 
variables were also significantly associated with decannulation in the ICU in the 
multivariate logistic regression model, making it possible to construct a propensity 
score for decannulation based on the coefficients of the logistic model. The quintile 
distribution showed moderate goodness of classification, with a prevalence of 
decannulation of 51%, 32%, 25%, 24%, and 17%, respectively, with a balanced 
distribution of the included variables in each quintile (Fig. 2). 
Both crude ward mortality (22% vs. 23%, p = .9) and time course of death were similar 
in decannulated and nondecannulated patients (Fig. 3). Additionally, in the Cox 
proportional hazard-ratio analysis after adjustment for the propensity score, only the 
Sabadell Score but not the presence of a tracheostomy can-nula remained significantly 
associated with ward survival (Table 3). In this analysis, the lack of decannulation in the 
ICU, with an odds ratio of 0.6 (0.3–1.2) (p = .1), failed to appear as a risk factor for 






The present study shows that a tracheostomy cannula in place during ward stay after 
ICU discharge did not increase the risk of mortality in a wide variety of hospitals with 
close surveillance in the ward. Because clinical characteristics may determine whether 
patients can be decannulated before ICU discharge, comparing ward survival in 
decannulated and nondecannulated patients requires strict adjustments for confounding 
factors. Our tracheostomy rate was low (13% of the MV patients); in most cases 
tracheostomy was performed for prolonged ICU stay and in sicker patients. These 
findings corroborate those of most previous studies (7, 8, 14), although Clec’h et al (6) 
found sicker patients in the nontracheostomized group. Nevertheless, even after 
tracheostomy, a quarter of the patients did not survive the acute illness in the ICU. 
Tracheostomized survivors have a worse subjective prognosis at ICU discharge than 
patients who did not need tracheostomy, and accordingly, their ward length of stay and 
ward mortality were higher. 
Our analysis of the differences among tracheostomized patients during the ICU stay 
revealed that decannulation was more likely in non-neurologic patients after a severe 
but reversible illness, as evidenced by the higher frequency of acute renal failure and 
ICU-acquired infections. In a recent survey in the United States, Stelfox et al (15) 
reported that respiratory therapists and physicians rated the patients’ ability to tolerate 
capping, secretions, cough effectiveness, and level of consciousness as the most 
important factors in the decision to decannulate, with respiratory therapists placing 
greater emphasis on the ability to tolerate capping and physicians on the level of 
consciousness. Similar results were recently reported in an international survey in 10 
developed countries by the same authors (16). 
The prognosis of ICU survivors is an unresolved issue in clinical practice be-cause 
general severity scores provide very little accuracy in this specific group of patients. 
The recently validated Sabadell Score (12) depicts four groups of patients with very 
different outcomes during ward hospitalization after ICU discharge. In the present 
study, the rate of nondecannulated patients classified as “poor short-term prognosis” or 
“expected hospital death” by the Sabadell Score was twice that of decannulated patients. 
Adjusting for this worse prognosis revealed a slight trend indicating that lack of 
decannulation was actually a protective factor instead of a risk factor for mortality. 
The present data contradict those of our previous single-center study (11), which 
suggested that ICU discharge to the ward with a cannula in place was a risk factor for 
mortality in the subgroup of patients with a poor prognosis, either in the short term or in 
the long term. However, the control group in that study was not only tracheostomized 
and decannulated patients but the whole population of MV patients. Additionally, the 
lack of a propensity analysis in that study meant that the comparison could not be 
adjusted to account for potentially confounding factors, such as the likelihood of 
decannulation. 
Some studies may be hindered by suboptimal treatment in the ward in patients with a 
cannula in place, as suggested by disproportionately early mortality (9). Recently, after 
systematically reviewing the literature, Garrubba et al (17) suggested that 
multidisciplinary teams in the ward may improve survival in tracheostomized patients 
but that the weakness of the studies reviewed precluded strong conclusions. Our ward 
survival curve shows a progressive decay in survival in both groups, with a slightly 
faster but statistically nonsignificant decay in decannulated patients, as suggested by a 
half-time mortality of 8 days in the decannulated group vs. 12 days in the 
nondecannulated group. Although we have no direct data about the appropriateness of 
care in the ward, these data suggested that no major flaws in medical care in the ward 
can account for our main results. 
An alternative explanation for the lack of survival advantage in patients decannulated 
before ICU discharge is that premature decannulation in some patients may expose them 
to secondary airway protection derangements in the ward. As a result, some attending 
physicians may consider that some of these patients are not candidates for reintubation. 
Conversely, they may consider patients discharged with a cannula in place as 
undergoing a low pacing process requiring frequent reassessment of overall recovery 
before moving to full decannulation.  
 
Limitations of the Study. Our study is limited by its observational design, which cannot 
exclude the possibility of our results being confounded by case-mix heterogeneity or 
secular trends. However, although a prospective, controlled, randomized clinical trial is 
the optimal means of demonstrating causality, appropriately designed observational 
studies with the right analytical strategies can provide valuable information on treatment 
effectiveness. Suarez et al (18) showed that, when analyzed with propensity score 
methodology, the results obtained in prospective, observational studies might be similar 
to those obtained in randomized, controlled trials. Furthermore, observational studies 
maximize external validity, and recent simulation research showed that propensity score 
methods generally gave treatment effect estimates that were closer to the true treatment 
effect than logistic regression models in which all confounders were modeled. The 
distribution of these confounders should be fairly equal between the treatment groups 
when estimating the effect of treatment on the outcome, as found in the present study. 
Nevertheless, our epidemiologic approach did not include other variables that can also 
act as confounders about the likelihood of decannulation, such as characteristics of 
secretions, coughing ability, or level of consciousness (9, 14). Our database also lacks 
data about body mass index, which has been suggested as a risk factor for mortality in 
the ward in tracheostomized patients (9). Additionally, “presumed good ward 
performance” is hard to define and lacks homogeneous criteria, so our operational 
definition relies only on the subjective perception of ICU physicians as to whether they 
confidently discharge patients to the ward with a tracheostomy cannula in place.  
The lack of a common ICU or ward decannulation protocol may have increased the 
variability of our results. Thus, although our results provide a picture of the day-to-day 
reality around Spain, we cannot rule out even better outcomes if these fragile patients 
were surveyed by dedicated teams during the ward stay, as has been recommended (10). 
The inclusion of the Sabadell Score as a factor in the survival analysis may be disputed 
because it is not widely used. Nevertheless, a secondary analysis excluding this score 
confirmed that a tracheostomy cannula in place was not a risk factor for mortality (data 
not shown) in our patients. Because attending physicians in the ward were unaware of 
the study, our results could not have been affected by the “Hawthorne effect,” i.e., the 
inadvertent modification of treatments induced by enrollment in a trial. 
We conclude that, in our multicenter setting, ICU discharge to the ward without 
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Figure 2. Box-plot chart showing balanced propensity scores for decannulated and 






















Figure 3. Survival curve for decannulated and nondecannulated patients in the ward (p 

























Figure 4. Cox proportional hazard function for ward survival of decannulated (dotted 
line) and nondecannulated (solid line) patients after adjustment for quintiles of the 




Table 1. Demographic data of tracheostomized and nontracheostomized mechanically 
ventilated patients 
Characteristic Tracheostomy(n = 260)
No Tracheostomy 
(n = 1,736) p 
Age, yrs 62.3 ± 16.0 61.5 ± 16.2 .5
Male sex 180 (69%) 1,128 (65%) .1
Predicted risk of death, % 37 ± 23 31 ± 26 .001
Source of admission  .001
Operating room 46 (18%) 670 (39%) 
Emergency room 101 (39%) 606 (35%) 
Ward 83 (32%) 343 (20%) 
Other 30 (11%) 117 (7%) 
Diagnostic group  .04
Postsurgical 41 (16%) 472 (28%) 
Cardiovascular 33 (13%) 380 (22%) 
Respiratory 59 (23%) 300 (17%) 
Neurologic 64 (25%) 273 (16%) 
Trauma 38 (15%) 115 (7%) 
Coronary 3 (1%) 44 (2%) 
Other 22 (8%) 152 (9%) 
Do-not-resuscitate orders on admission 18 (7%) 113 (6%) .4
Vasoactive drugs 218 (84%) 1082 (62%) .001
Transfusion 170 (65%) 665 (38%) .001
Acute renal failure 95 (36%) 483 (28%) .003
Parenteral nutrition 119 (46%) 389 (22%) .001
Noninvasive ventilation 55 (21%) 233 (13%) .001
ICU-acquired infection 183 (70%) 216 (12%) .001
ICU length of stay, days 28.5 (17–41) 5 (3–10) .001
ICU mortality 59 (23%) 418 (24%) .9
Prognosis at ICU discharge  .001
Good prognosis 49 (19%) 870 (50%) 
Poor long-term prognosis 67 (26%) 296 (17%) 
Poor short-term prognosis 52 (20%) 114 (7%) 
Expected to die in hospital 33 (13%) 38 (2%) 
Ward length of stay, days 12.5 (1–34) 8 (1–15) .001
Hospital mortality 104 (40%) 509 (29%) .001













Table 2. Clinical variables of tracheostomized patients classified according to 
whether they were decannulated in the intensive care unit
Characteristic Decannulated(n = 60)
Nondecannulated 
(n = 141) p 
Age, yrs 61.3 ± 17.0 60.2 ± 16.9 .7
Male sex 44 (73%) 94 (67%) .2
Predicted risk of death, % 35 ± 23.9 33 ± 21.1 .5
Source of admission .4
Operating room 13 (22%) 20 (14%)  
Emergency room 22 (37%) 63 (45%)  
Ward 19 (32%) 39 (28%)  
Other 6 (10%) 19 (13%)  
Diagnostic group .02
Postsurgical 11 (18%) 19 (13%)  
Cardiovascular 10 (17%) 11 (8%)  
Respiratory 15 (25%) 29 (21%)  
Neurologic 9 (15%) 45 (32%)  
Trauma 8 (13%) 28 (20%)  
Coronary 2 (3%) 0 (0%)  
Other 5 (8%) 9 (6%)  
Do-not-resuscitate orders on admission 4 (7%) 6 (4%) .3
Vasoactive drugs 54 (90%) 107 (76%) .01
Transfusion 42 (70%) 84 (60%) .1
Acute renal failure 22 (37%) 33 (23%) .04
Parenteral nutrition 33 (55%) 47 (33%) .003
Noninvasive ventilation 12 (20%) 27 (19%) .5
ICU-acquired infection 38 (63%) 100 (71%) .2
ICU length of stay, days 29.5 (18–41.5) 27 (16–40) .3
Prognosis at ICU discharge .002
Good prognosis 24 (40%) 25 (18%)  
Poor long-term prognosis 21 (35%) 46 (33%)  
Poor short-term prognosis 9 (15%) 43 (30%)  
Expected to die in hospital 6 (10%) 27 (19%)  
ICU readmission 6 (11%) 7 (5%) .1
Ward length of stay, days 14 (7–32) 25 (9–49) .01
Hospital mortality 13 (22%) 32 (23%) .5















Table 3. Cox proportional hazards analysis for ward mortality. 
Term Hazard Ratio (95% Confidence Interval) p 
Nondecannulation 0.6 (0.3–1.2) .1
Sabadell Score (1 vs. 0) 6.9 (0.9–56.0) .07
Sabadell Score (2 vs. 0) 25.4 (3.3–197.1) .002
Sabadell Score (3 vs. 0) 59.4 (7.8–453.7) .001
Quintile (2 vs. 1) 0.5 (0.2–1.4) .2
Quintile (3 vs. 1) 0.3 (0.1–0.9) .05
Quintile (4 vs. 1) 0.8 (0.3–2.0) .5
Quintile (5 vs. 1) 0.7 (0.3–1.9) .6
 
 
